ArticleAmerican journal of cancer research2025
Comparative outcomes of transurethral resection of the prostate and prostate kinetic resection in treating benign prostatic hyperplasia with prostatic stones.
Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo compare the clinical outcomes of transurethral bipolar plasma enucleation (TBPE) and transurethral resection of the prostate (TURP) in patients with benign prostatic hyperplasia (BPH) complicated by prostatic stones.
methodsThis retrospective study included 150 patients divided into TBPE (n = 74) and TURP (n = 76) groups. Perioperative data, urodynamic parameters, symptom scores, complications, and sexual function were evaluated up to 6 months postoperatively.
resultsTBPE was associated with shorter catheterization and hospital stay, greater improvements in maximum urinary flow rate, post-void residual volume, and International Prostate Symptom Score, fewer complications, less intraoperative bleeding, and better postoperative sexual function (all P < 0.001). Multivariate analysis confirmed TBPE as an independent predictor of favorable outcomes (OR = 12.074, 95% CI: 6.513-22.386, P < 0.001).
conclusionTBPE demonstrates superior clinical effectiveness and safety over TURP for managing BPH with prostatic stones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.